Clinical Trial Update: US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study [Phase 2]

View source ↗

Summary

Phase 2 study of Biologic Lung Volume Reduction (BLVR) for pulmonary emphysema has completed enrollment/status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Emphysema

Drugs mentioned

• Biologic Lung Volume Reduction (BLVR)

Snippet

Sponsor: Aeris Therapeutics | Conditions: Pulmonary Emphysema | Phase 2 | Status: COMPLETED